Recursion Pharmaceuticals Inc

13 lis 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. shares are lower in after-market trading, declining from an early peak and remaining significantly below their 20-day moving average.

12 lis 2026, 23:51 UTC

Recursion Pharmaceuticals, Inc. is moving higher in after-market trading, reflecting broader market gains, despite a modest decline from earlier highs.

11 lis 2026, 22:51 UTC

Recursion Pharmaceuticals, Inc. is moving lower in after-market hours amid a broader market decline and rising U.S. Treasury yields due to inflation concerns.

10 lis 2026, 21:02 UTC

Recursion Pharmaceuticals, Inc. shares fell sharply today, continuing a decline since Monday's close, amid mixed signals from recent macroeconomic data releases.

9 lis 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. shares declined modestly in after-market trading, retracing from an earlier uptick and reaching a low in its one-month range.

6 lis 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. is trading higher in after-market hours, reaching its highest level since Friday's close.

5 lis 2026, 23:22 UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, in line with a broader market decline and losses in the ARK Genomic Revolution ETF (ARKG).

4 lis 2026, 21:04 UTC

Recursion Pharmaceuticals shares are rising during Wednesday's session, following a broader biotechnology sector increase and strong gains in the SPDR S&P Biotech ETF.

3 lis 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. is moving higher in after-market hours, reflecting broader market gains amid strong economic data influencing Federal Reserve policy.

2 lis 2026, 23:02 UTC

Recursion Pharmaceuticals appointed Fred Hassan as Chair of the Board, effective October 31, 2026, and reported positive Phase 2 data for REC-4881.

31 paź 2026, 00:01 UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, having declined from Friday's close amid volatility and stabilization near its one-month range.

30 paź 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. declined during after-market hours, with cumulative returns falling since Friday's close after briefly peaking earlier in the session.

29 paź 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. shares declined during after-market hours on Thursday, breaking a trend of higher daily closes established earlier in the week.

28 paź 2026, 23:02 UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, reflecting the broader market's decline and retracing from an earlier session high.

27 paź 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. is declining in after-market hours, marking a significant retracement from recent highs after finishing higher for three consecutive sessions.

26 paź 2026, 20:07 UTC

Recursion Pharmaceuticals Inc shares are advancing, having reached an early peak but ultimately settling lower near the lower end of their one-month range.

24 paź 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares are trading lower in after-market hours, having retraced from a brief peak earlier in the session.

23 paź 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

22 paź 2026, 23:02 UTC

Recursion Pharmaceuticals Inc is experiencing a significant decline in after-market trading, moving lower since Thursday's close and reaching its lowest point of the day.

21 paź 2026, 23:51 UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, reflecting broader market trends and positioning below its 20-day moving average.

20 paź 2026, 23:02 UTC

Recursion Pharmaceuticals Inc shares are trading modestly lower in after-market hours, with approximately $561 million in cash at the end of the quarter.

19 paź 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, maintaining an upward trajectory since Monday's close.

17 paź 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced modestly higher during after-market hours on Friday, diverging from the recent trend of higher daily closes.

16 paź 2026, 23:06 UTC

Recursion Pharmaceuticals Inc shares are modestly higher in after-market trading.

15 paź 2026, 20:03 UTC

Recursion Pharmaceuticals announces a $200 million oversubscribed follow-on offering and positive updates on drug candidate REC-4881, achieving a 47% median reduction in polyp burden.

14 paź 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, aligning with broader market losses amid rising inflation concerns and geopolitical tensions affecting oil supply.

13 paź 2026, 23:06 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours following Tuesday's close.

12 paź 2026, 20:02 UTC

Recursion Pharmaceuticals Inc shares are sharply lower, continuing a downward trend since Friday, despite an early spike in today's trading session.

10 paź 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced during after-market hours on Friday, despite earlier pulling back from a session high.

9 paź 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from an earlier decline while remaining well above its 20-day moving average.